WHO Grade III or IV Recurrent Glioma
1 clinical trials · Condition
◉ Watch WHO Grade III or IV Recurrent Glioma
| Record | Firm | Date |
|---|---|---|
| Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma (NCT02278510) | Michael Vogelbaum, MD, PhD | 2014-12-09 |
Track WHO Grade III or IV Recurrent Glioma automatically
Every clearance here is in the API, with alerts when new ones post.